Overexpression of PD-L1 is an Independent Predictor for Recurrence in HCC Patients Who Receive Sorafenib Treatment After Surgical Resection

OBJECTIVE: The predicting values of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) were unclear in Hepatocellular carcinoma (HCC) patients who receive sorafenib treatment after curative hepatic resection. METHODS: We retrospectively enrolled HCC patients who received adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yifei, Xu, Qing, Wu, Zhenru, Zhang, Wei, Li, Bo, Zhang, Bohan, Xu, Xi, Zhang, Bo, Yan, Ke, Song, Jiulin, Lv, Tao, Yang, Jian, Jiang, Li, Shi, Yujun, Yang, Jiayin, Yan, Lunan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804345/
https://www.ncbi.nlm.nih.gov/pubmed/35117990
http://dx.doi.org/10.3389/fonc.2021.783335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804345/
https://www.ncbi.nlm.nih.gov/pubmed/35117990
http://dx.doi.org/10.3389/fonc.2021.783335

Ejemplares similares